Wednesday, January 09, 2019 4:55:20 PM
I Dabbled in some cheap call options and we will see what happens. With a MC this low and science that I think is valuable, this seems like it makes sense. I just remember the aldox days when we were all excited about the lung cancer trial results that we never got and the big partnership deal we were expecting. As it is now, Soon controls Aldox and it looks like it is going through multiple trials so there could be some upside but CYTR has really nothing to do with it anymore. Then you have the LADR tech, but it seems like early positive results have cause CYTR to shut down trials looking for a deal. So I have a company that created apparently awesome tech, but is now doing nothing. I am somewhat optimistic that paying off the debt, owning LADR tech, closing Germany Lab, creating a spin off company (tho wholly owned by CYTR), the recent lack of shorting, and the Sabby long (please be long) investment all point to a transaction that will once and for all be beneficial to all shareholders....cause if not, I have no idea what they are doing?
Good luck to all!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM